A 50-year-old woman, HIV-positive, receiving HAART (highly active antiretroviral therapy), presented with atraumatic pain and swelling in both the ankles and feet, which she had had for years and which had recently become acute. She had never received corticosteroids and there were no other risk factors.
Ultrasound and X-ray did not show pathological features.
Magnetic resonance imaging (MRI) was performed using a Symphony Magnetom Maestro Class 1.5-T MRI system (Siemens Medical Solutions, Malvern, NJ, USA). Sagittal T1-weighted, sagittal, coronal and axial DP fat sat sequences were performed. Bilaterally, MRI showed areas of abnormal signal, with irregular margins in the distal third of the tibia, in the astragalus and calcaneus, related to severe subchondral ischaemia and bone oedema, suggesting osteonecrosis.
Tibio-astragalic and subastragalic joint effusion and insufficiency fractures of both the astragalus bones and of the proximal epiphysis of left tibia coexisted.
Osteonecrosis (or ‘avascular necrosis of bone’) derives from the death of cellular elements of bone causing skeletal pain. It is supposed to be the result of the interruption of the blood supply to the affected bone [1] and it has been attributed to: altered arterial blood viscosity, impaired arterial blood supply, the replacement of intraosseous vascular tissue with non-vascular tissue, a decreased arterial inflow due to increased intraosseous pressure, or hypertension caused by reduced venous drainage [2].
Alcohol abuse, dyslipidaemia, haemoglonbinopathies, hypercoagulable states and systemic corticosteroids are the most common risk factors for osteonecrosis.
Osteonecrosis is described as a rare complication in patients with HIV [3-4], with unclear and multifactorial pathogenesis [2-3]. The main risk factors are: anti-phospholipid and anti-cardiolipin antibodies [5], increased triglycerides, chronic treatment with steroids or megestrol acetate, caloric deprivation [2-6], and the use of protease inhibitors [7].
The role of HAART, instead, is still controversial.
It has been associated with several metabolic complications, determining osteopenia and osteoporosis [8]. The mechanisms involved are: (1) enhanced humoral immunity, causing increased production of anti-protein S or antiphospholipid antibodies; (2) hyperlipidemia and (3) abnormal fat distribution [9-10-1], which determine peripheral insulin resistance, inhibition of lipoprotein-lipase (by TNF-α), suppression of HIV replication and changes in endocrine homeostasis [11]. Immunomodulating effects are also associated with rise in serum osteocalcin levels [12].
In HIV-infected patients, bone disease can affect one or multiple sites and causes pain and swelling of the joints involved. In particular, in the English language literature, the hip represents the most common site of involvement, followed by the knee and the shoulder [7], while the ankle, especially bilaterally, is very rarely involved.
MRI and scintigraphy are currently the best methods to recognize the condition and establish a correct diagnosis [3], while the role of conventional X-ray and ultrasound appears unremarkable.
MRI can show several pathological features, which can be surely related to ischaemia, suggesting osteonecrosis.
MRI appears to be the most reliable and safe imaging technique available in the recognition of osteonecrosis.
Moreover, it has been suggested that systemic corticosteroids can represent a risk factor for osteonecrosis. In spite of this, our patient has received HAART, but has never been treated with corticosteroids.
Awareness of its potentiality should induce MRI to be encouraged as a valid method to diagnose osteonecrosis.
In addition, clinicians should be aware that HAART can play a leading role in determining the onset of osteonecrosis in HIV-infected patients, independently of other risk factors, especially systemic corticosteroids.
HIV-related osteonecrosis of the ankles and feet
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Based on the provided MRI images, abnormalities in signal can be observed in both ankle joints (talus, calcaneus, and surrounding relevant structures) to varying degrees, primarily manifested as:
Overall, these imaging findings are consistent with ischemic bone necrosis (osteonecrosis) in the ankle joint, particularly prominent in the talus.
Taking into account the patient's profile — 50-year-old female, HIV-positive and on HAART, a long history of ankle pain with recent exacerbation, no clear history of trauma, and the imaging findings — the following potential diagnoses are considered:
Combining the patient's medical history (HIV-positive, long-term on HAART), clinical symptoms (chronic bilateral ankle pain with a recent acute exacerbation), and imaging findings (MRI showing characteristics of ischemic necrosis of bone), the most likely diagnosis is:
Osteonecrosis affecting multiple areas, including the talus and calcaneus.
For further confirmation, additional clinical tests (such as blood lipids, coagulation function, and antiphospholipid antibody levels) and monitoring the progression of symptoms are recommended to exclude other possibilities.
Rehabilitation should focus on protecting the joint, maintaining muscle strength, and promoting blood circulation, following the FITT-VP principles (Frequency, Intensity, Time, Type, Progression, and Individualization).
This report is a reference analysis based on the existing medical history and imaging data; it cannot replace in-person consultations or professional clinical diagnostic and treatment advice. The patient should undergo further examinations and clinical assessment at professional medical facilities to obtain an individualized treatment plan.
HIV-related osteonecrosis of the ankles and feet